SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020625
Filing Date
2017-11-01
Accepted
2017-11-01 06:33:08
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-10q_20170930.htm 10-Q 1874121
2 EX-31.1 amrn-ex311_6.htm EX-31.1 16352
3 EX-31.2 amrn-ex312_10.htm EX-31.2 16757
4 EX-32.1 amrn-ex321_9.htm EX-32.1 9905
  Complete submission text file 0001564590-17-020625.txt   7247554

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amrn-20170930.xml EX-101.INS 1584394
6 XBRL TAXONOMY EXTENSION SCHEMA amrn-20170930.xsd EX-101.SCH 48855
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20170930_cal.xml EX-101.CAL 42000
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20170930_def.xml EX-101.DEF 199859
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20170930_lab.xml EX-101.LAB 399158
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20170930_pre.xml EX-101.PRE 320031
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 171167271
SIC: 2834 Pharmaceutical Preparations